Date: Tuesday 21 June
Time: 15.40 - 16.55
Stream: New science

This session will review potential treatment strategies for dementia based on inflammation, protein handling, glucose metabolism and tau phosphorylation and clinical trials which target these.

Chair: Professor John O'Brien, University of Cambridge

Inflammation as a therapeutic target in alzheimer's disease

Dr Vanessa Raymont, University of Oxford

Lithium and other inhibitors of tau phosphorylation

Dr Ross Dunne, University of Manchester

Protein production, degradation and glucose metabolism